Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation
INSPIRE
Intrapulmonary Volume Changes During Synchronized Noninvasive Positive Pressure Ventilation In Preterm Infants
1 other identifier
observational
27
1 country
1
Brief Summary
Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedStudy Start
First participant enrolled
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2027
December 9, 2025
December 1, 2025
1.1 years
November 14, 2025
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tidal volume (VT)
Difference in relative VT (rel. ΔZ) between spontaneous breaths and synchronized inflations.
At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Secondary Outcomes (12)
Global lung impedance
At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Regional tidal volume distribution
At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Center of ventilation
At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Silent spaces
At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
Global inhomogeneity index
At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.
- +7 more secondary outcomes
Study Arms (1)
Preterm infants with a gestational age < 30 0/7 weeks at birth
Infants on sNIPPV respiratory support and below 4 weeks chronological age
Interventions
Electrical Impedance Tomography and clinical data will be recorded continuously. Corresponding data will be extracted and analyzed at five pre-defined timepoints.
Eligibility Criteria
This study will take place at the Department of Neonatology of the University Hospital Zurich. Preterm infants on a synchronized mode of non-invasive positive pressure ventilation will be screened for eligibility and parents will be approached by the treating physician or a clinician-researcher who is authorized to access the patient's clinical data.
You may qualify if:
- Written informed consent by one or both parents or legal guardians
- Gestational age at birth \< 30 0/7 weeks
- Infants on sNIPPV respiratory support
- Below 4 weeks chronological age
You may not qualify if:
- Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects)
- Too ill/unstable in the opinion of the treating physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- University Hospital, Zürichcollaborator
Study Sites (1)
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Vincenzo Cannizzaro, MD
Newborn Research, Department of Neonatology, University Hospital and University of Zurich, Zurich, Switzerland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 19, 2025
Study Start
November 17, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 30, 2027
Last Updated
December 9, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share